Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers

Clinical trial NCT04171219 · TERMINATED

Trial details

NCT number: NCT04171219
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Recurrent Malignant Solid Neoplasm

Start date: 2020-03-19
Primary completion: 2025-03-11
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.